Cinven Partners LLP DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

7 News #PharmaBuzz

media
7 News #PharmaBuzz

DEVELOPMENTS

57 Drugs in Development

57 Drugs in Development

FINISHED DOSAGE FORMULATIONS

4 FDF Dossiers, 4 FDA Orange Book

4 FDF Dossiers
4 FDA Orange Book

INSPECTIONS & REGISTRATIONS

24 FDA

inspections
24 FDA

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cinven is a leading international private equity firm, founded in 1977, with offices in London, Frankfurt, Guernsey, Hong Kong, Luxembourg, Madrid, Milan, New York and Paris. Funds managed by Cinven acquire companies with a European focus that will benefit from Cinven's expertise of growing and building companies globally and require an equity investment of €200 million or more. Cinven can also invest selectively in businesses in North America. Cinven's Portfolio team helps our portfolio companies take advantage of international best practices and growth in global markets, including those in Asia and the Americas. Cinven uses a matrix of sector and country experience to invest in companies where it can strategically drive revenue growth. We focus on six sectors: Business Services, Consumer, Financial Services, Healthcare, Industrials, and Technology, Media and Telecommunications (TMT) and have invested in companies in 15 countries. Cinven funds acquire successful, high-quality companies and work with them to help them grow and develop, using our proven value creation strategies. The typical holding period for an investment is between four and six years. We take a responsible approach towards our portfolio companies, their employees, suppliers and local communities, the environment and society. Cinven has built a strong track record over 25 years investing successfully through economic cycles. Cinven is currently investing the Sixth Cinven Fund. Cinven is partner owned. The Cinven Funds are managed by Cinven Limited, Cinven Capital Management (V) General Partner Limited and Cinven Capital Management (VI) General Partner Limited (the 'Guernsey Managers'). The Boards of the Guernsey Managers supervise the governance of the Cinven Funds. Cinven's only business is the management of private equity funds, so the issue of potential conflicts of interest in respect of corporate advisory work does not apply to the firm.